JO
TEVA icon

John Overdeck’s Teva Pharmaceuticals TEVA Stock Holding History

John Overdeck’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84M Sell
231,287
-135,504
-37% -$4.51M 0.01% 1717
2026
Q1 		$11M Buy
366,791
+138,970
+61% +$4.47M 0.01% 1342
2025
Q4 		$7.11M Buy
227,821
+107,424
+89% +$2.65M 0.01% 1391
2025
Q3 		$2.43M Sell
120,397
-199,497
-62% -$3.5M ﹤0.01% 2001
2025
Q2 		$5.36M Buy
319,894
+183,097
+134% +$2.95M 0.01% 1184
2025
Q1 		$2.1M Sell
136,797
-549,658
-80% -$9.82M ﹤0.01% 1703
2024
Q4 		$15.1M Sell
686,455
-28,694
-4% -$522K 0.03% 582
2024
Q3 		$12.9M Buy
715,149
+577,549
+420% +$10.1M 0.03% 651
2024
Q2 		$2.24M Buy
137,600
+3,851
+3% +$59.3K 0.01% 1484
2024
Q1 		$1.89M Sell
133,749
-17,951
-12% -$226K ﹤0.01% 1526
2023
Q4 		$1.58M Sell
151,700
-1,270
-0.8% -$11.9K ﹤0.01% 1772
2023
Q3 		$1.56M Sell
152,970
-589,823
-79% -$5.49M ﹤0.01% 1619
2023
Q2 		$5.59M Sell
742,793
-406,156
-35% -$3.29M 0.01% 874
2023
Q1 		$10.2M Sell
1,148,949
-4,412,717
-79% -$43.6M 0.03% 584
2022
Q4 		$50.7M Buy
5,561,666
+278,165
+5% +$2.43M 0.16% 154
2022
Q3 		$42.6M Buy
5,283,501
+4,627,252
+705% +$40.9M 0.14% 180
2022
Q2 		$4.93M Buy
656,249
+139,200
+27% +$1.21M 0.02% 782
2022
Q1 		$4.86M Sell
517,049
-463,147
-47% -$3.87M 0.01% 944
2021
Q4 		$7.85M Buy
980,196
+282,576
+41% +$2.55M 0.02% 922
2021
Q3 		$6.79M Buy
697,620
+686,986
+6,460% +$6.43M 0.02% 1004
2021
Q2 		$105K Buy
+10,634
New +$113K ﹤0.01% 3891
2020
Q4 		– Sell
-95,048
Closed -$856K – 3756
2020
Q3 		$856K Sell
95,048
-721,451
-88% -$7.63M ﹤0.01% 1865
2020
Q2 		$10.1M Sell
816,499
-858,680
-51% -$9.71M 0.05% 389
2020
Q1 		$15M Sell
1,675,179
-1,477,722
-47% -$15.1M 0.12% 171
2019
Q4 		$30.9M Buy
3,152,901
+2,389,053
+313% +$21.3M 0.09% 259
2019
Q3 		$5.25M Buy
763,848
+752,948
+6,908% +$5.77M 0.02% 835
2019
Q2 		$101K Sell
10,900
-3,030,927
-100% -$36.5M ﹤0.01% 3201
2019
Q1 		$47.7M Buy
+3,041,827
New +$53.6M 0.15% 168
2018
Q4 		– Sell
-371,883
Closed -$8.01M – 3515
2018
Q3 		$8.01M Sell
371,883
-1,587,975
-81% -$36.9M 0.02% 739
2018
Q2 		$47.7M Buy
1,959,858
+1,763,766
+899% +$36M 0.14% 179
2018
Q1 		$3.35M Sell
196,092
-1,107,214
-85% -$21.6M 0.01% 1176
2017
Q4 		$24.7M Buy
1,303,306
+1,204,574
+1,220% +$18.1M 0.08% 322
2017
Q3 		$1.74M Buy
+98,732
New +$2.22M 0.01% 1386
2017
Q2 		– Sell
-2,022,219
Closed -$62.6M – 3271
2017
Q1 		$64.9M Sell
2,022,219
-1,898,726
-48% -$64.8M 0.22% 109
2016
Q4 		$142M Buy
3,920,945
+1,359,431
+53% +$54.3M 0.55% 20
2016
Q3 		$118M Buy
2,561,514
+412,598
+19% +$21.5M 0.43% 45
2016
Q2 		$108M Buy
2,148,916
+85,631
+4% +$4.56M 0.46% 35
2016
Q1 		$110M Buy
2,063,285
+1,483,102
+256% +$87M 0.53% 28
2015
Q4 		$38.1M Sell
580,183
-1,164,814
-67% -$72M 0.18% 141
2015
Q3 		$98.5M Sell
1,744,997
-424,460
-20% -$27.5M 0.5% 45
2015
Q2 		$128M Buy
2,169,457
+328,632
+18% +$20.3M 0.6% 16
2015
Q1 		$115M Buy
1,840,825
+31,800
+2% +$1.85M 0.53% 23
2014
Q4 		$104M Buy
1,809,025
+38,869
+2% +$2.17M 0.58% 21
2014
Q3 		$95.1M Sell
1,770,156
-41,182
-2% -$2.18M 0.43% 53
2014
Q2 		$95M Buy
1,811,338
+1,668,827
+1,171% +$85.3M 0.43% 39
2014
Q1 		$7.53M Sell
142,511
-472,352
-77% -$21.8M 0.04% 513
2013
Q4 		$24.6M Buy
614,863
+312,886
+104% +$12.3M 0.14% 198
2013
Q3 		$11.4M Sell
301,977
-618,199
-67% -$24.1M 0.07% 322
2013
Q2 		$36.1M Buy
+920,176
New +$35.8M 0.25% 97

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

John Overdeck's TEVA Position: Q2 2026 in Review

John Overdeck reduced its Teva Pharmaceuticals (TEVA) stake by 37% in Q2 2026, selling an estimated $4.51M and leaving 231,287 shares worth $7.84M. The position accounts for 0.01% of the portfolio, ranked #1717.

John Overdeck first reported a position in TEVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $142M in Q4 2016. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • John Overdeck held 231,287 shares of Teva Pharmaceuticals worth $7.84M as of Q2 2026.
  • John Overdeck sold 135,504 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.51M.
  • Teva Pharmaceuticals made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1717 holding.
  • John Overdeck first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • John Overdeck's Teva Pharmaceuticals position peaked at $142M in Q4 2016.
  • 671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.